Advisor Shares Investments LLC Seelos Therapeutics, Inc. Transaction History

Advisor Shares Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$0.16 - $1.64 $52,178 - $534,828	326,115 Added 110.47%	621,317 $111,000
Q2 2023 Aug 09, 2023	SELL	$0.66 - $1.22 $68,594 - $126,795	-103,931 Reduced 26.04%	295,202 $354,000
Q1 2023 May 09, 2023	BUY	$0.59 - $1.04 $15,369 - $27,092	26,050 Added 6.98%	399,133 $275,000
Q4 2022 Feb 14, 2023	SELL	$0.66 - $1.34 $64,064 - $130,071	-97,068 Reduced 20.65%	373,083 $253,000
Q3 2022 Nov 14, 2022	BUY	$0.65 - $1.41 $68,610 - $148,831	105,554 Added 28.95%	470,151 $484,000

Q2 2022 Aug 08, 2022	BUY	$0.51 - $0.93 $2,958 - $5,394	5,801 Added 1.62%	364,597 $248,000
Q1 2022 May 09, 2022	BUY	$0.84 - $1.71 $136,179 - $277,223	162,119 Added 82.43%	358,796 $301,000
Q4 2021 Jan 31, 2022	BUY	$1.59 - $2.38 $230,418 - $344,902	144,917 Added 279.98%	196,677 $321,000
Q3 2021 Nov 04, 2021	BUY	$1.69 - $2.89 $87,474 - $149,586	51,760 New	51,760 $125,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $59.7M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Advisor Shares Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Advisor Shares Investments LLC with notifications on news.